• 1
    Otter R. Non-Hodgkin's lymphoma in a population-based registry [dissertation]. The Hague, The Netherlands: J. H. Pasmans B.V., 1989.
  • 2
    Corn BW, Marcus SM, Topham A, Hauck W, Curran WJ. Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000? Cancer. 1997; 79: 24092413.
  • 3
    Lutz JM, Coleman MP. Trends in primary cerebral lymphoma. Br J Cancer. 1994; 70: 716718.
  • 4
    Krogh-Jensen M, D'Amore F, Jensen MK, et al. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry. Leuk Lymphoma. 1995;19: 223233.
  • 5
    Hao D, Di Francesco LM, Brasher PM, et al. Is primary CNS lymphoma really becoming more common? A population-based study of incidence, clinicopathological features and outcomes in Alberta from 1975 to 1996. Ann Oncol. 1999;10: 6570.
  • 6
    Coté TR, Manns A, Hardy CR, Yellin FJ, Hartge P, and the AIDS/Cancer Study Group. Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. J Natl Cancer Inst. 1996; 88:675679.
  • 7
    Yau Y-H, O'Sullivan MG, Signorini D, Ironside JW, Whittle IR. Primary lymphoma of central nervous system in immunocompetent patients in south-east Scotland. Lancet. 1996; 348: 890.
  • 8
    Au WY, Chan ACL, Srivastava G, Leung SY, Liang R. Incidence and pathology of primary brain lymphoma in Hong Kong Chinese patients. Leuk Lymphoma. 2000;37: 175179.
  • 9
    Fine HA, Mayer RJ. Primary central nervous system lymphoma. Ann Intern Med. 1993; 119: 10931104.
  • 10
    DeAngelis LM. Primary central nervous system lymphoma: a new clinical challenge. Neurology. 1991; 41: 619621.
  • 11
    Hayabuchi N, Shibamoto Y, Onizuka Y and JASTRO CNS Lymphoma Study Group Members. Primary central nervous system lymphoma in Japan: a nationwide survey. Int J Radiat Oncol Biol Phys. 1999;44: 265272.
  • 12
    Miller DC, Hochberg FH, Harris NL, Gruber ML, Louis DN, Cohen H. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma: the Massachusetts General Hospital experience 1958-1989. Cancer. 1994; 74: 13831397.
  • 13
    DeAngelis LM. Primary CNS lymphoma: treatment with combined chemotherapy and radiotherapy. J Neurooncol. 1999; 43: 249257.
  • 14
    Van der Sanden GAC, Schouten LJ, Van Dijck JAAM, Van Andel JP, Coebergh JWW on behalf of specialists in neuro-oncology in South and East Netherlands. Incidence of primary central nervous system cancers in South and East Netherlands in 1989-1994. Neuroepidemiology. 1998;17: 247257.
  • 15
    Plummer M. Age standardization. In: ParkinDM, WhelanSL, FerlayJ, RaymondL, YoungJ, editors. Cancer incidence in five continents. Volume VII. IARC Scientific Pub. No. 143. Lyon, France: International Agency for Research on Cancer, 1997: 6668.
  • 16
    Raad voor Gezondheidsonderzoek (RGO). Good behavior. Behavior Code for Health Research [in Dutch]. The Hague, The Netherlands: Name of publishing company, 1995.
  • 17
    Van der Sanden GAC, Schouten LJ, Coebergh JWW on behalf of specialists in neuro-oncology in Southeastern Netherlands. Incidence of primary cancer of the central nervous system in southeastern Netherlands during the period 1980-94. Cancer Causes Control. 1998;9: 225228.
  • 18
    Coebergh JWW, Van der Heijden LH. Non-Hodgkin's lymphoma. In: CoeberghJWW, Van der HeijdenLH, Janssen-HeijnenMLG, editors. Cancer incidence and survival in the Southeast of the Netherlands 1955-1994: a report from the Eindhoven Cancer Registry. Eindhoven, The Netherlands: Comprehensive Cancer Centre South (IKZ), 1995: 8486.
  • 19
    Paulus W. Classification, pathogenesis and molecular pathology of primary CNS lymphomas. J Neurooncol. 1999; 43: 203208.
  • 20
    Braus DF, Schwechheimer K, Müller-Hermelink HK, Schwarzkopf G, Volk B, Mundinger F. Primary cerebral malignant non-Hodgkin's lymphomas: a retrospective clinical study. J Neurol. 1992; 239: 117124.
  • 21
    Bataille B, Delwail V, Menet E, et al. Primary intracerebral lymphoma: report of 248 cases. J Neurosurg. 2000; 92: 261266.
  • 22
    Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994; 84: 13611392.
  • 23
    Villegas E, Villà S, López-Guillermo A, Petit J, Ribalta T, Graus F. Primary central nervous system lymphoma of T-cell origin: description of two cases and review of the literature. J Neurooncol. 1997; 34: 157161.
  • 24
    Health State Control /Inspectie voor de Gezondheidszorg. Aids in the Netherlands at December 31 1998 [in Dutch]. The Hague, The Netherlands: Name of publisher, 1999.
  • 25
    Chow KU, Mitrou PS, Geduldig K, Helm EB, Hoelzer D, Brodt HR. Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART). Leuk Lymphoma. 2001; 41: 105116.